DLD Asset Management »

Tg Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 30k 54.94
2022-03-31 $594k 63k 9.50

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
D. E. Shaw & Co
Soleus Capital Management
ClearBridge Advisors
Congress Asset Management
Two Sigma Investments
Jane Street
Goldman Sachs Group
Susquehanna International
Pictet Asset Management Holding SA
Nuveen

View all funds holding Tg Therapeutics